194 related articles for article (PubMed ID: 8445034)
1. 11 beta-Hydroxysteroid dehydrogenase deficiency and glucocorticoid status in patients with alcoholic and non-alcoholic chronic liver disease.
Stewart PM; Burra P; Shackleton CH; Sheppard MC; Elias E
J Clin Endocrinol Metab; 1993 Mar; 76(3):748-51. PubMed ID: 8445034
[TBL] [Abstract][Full Text] [Related]
2. 11 beta-Hydroxysteroid dehydrogenase activity in Cushing's syndrome: explaining the mineralocorticoid excess state of the ectopic adrenocorticotropin syndrome.
Stewart PM; Walker BR; Holder G; O'Halloran D; Shackleton CH
J Clin Endocrinol Metab; 1995 Dec; 80(12):3617-20. PubMed ID: 8530609
[TBL] [Abstract][Full Text] [Related]
3. Induction of hepatic 11beta-hydroxysteroid dehydrogenase type 1 in patients with alcoholic liver disease.
Ahmed A; Saksena S; Sherlock M; Olliff SP; Elias E; Stewart PM
Clin Endocrinol (Oxf); 2008 Jun; 68(6):898-903. PubMed ID: 18031327
[TBL] [Abstract][Full Text] [Related]
4. Absence of Cushingoid phenotype in a patient with Cushing's disease due to defective cortisone to cortisol conversion.
Tomlinson JW; Draper N; Mackie J; Johnson AP; Holder G; Wood P; Stewart PM
J Clin Endocrinol Metab; 2002 Jan; 87(1):57-62. PubMed ID: 11788623
[TBL] [Abstract][Full Text] [Related]
5. Urinary free cortisone and the assessment of 11 beta-hydroxysteroid dehydrogenase activity in man.
Palermo M; Shackleton CH; Mantero F; Stewart PM
Clin Endocrinol (Oxf); 1996 Nov; 45(5):605-11. PubMed ID: 8977758
[TBL] [Abstract][Full Text] [Related]
6. Cortisol metabolism in the postoperative period after cardiac surgery.
Vogeser M; Felbinger TW; Röll W; Jacob K
Exp Clin Endocrinol Diabetes; 1999; 107(8):539-46. PubMed ID: 10612485
[TBL] [Abstract][Full Text] [Related]
7. Cortisol metabolism in healthy young adults: sexual dimorphism in activities of A-ring reductases, but not 11beta-hydroxysteroid dehydrogenases.
Finken MJ; Andrews RC; Andrew R; Walker BR
J Clin Endocrinol Metab; 1999 Sep; 84(9):3316-21. PubMed ID: 10487705
[TBL] [Abstract][Full Text] [Related]
8. The effect of growth hormone replacement therapy on cortisol-cortisone interconversion in hypopituitary adults: evidence for growth hormone modulation of extrarenal 11 beta-hydroxysteroid dehydrogenase activity.
Gelding SV; Taylor NF; Wood PJ; Noonan K; Weaver JU; Wood DF; Monson JP
Clin Endocrinol (Oxf); 1998 Feb; 48(2):153-62. PubMed ID: 9579226
[TBL] [Abstract][Full Text] [Related]
9. Altered cortisol metabolism in polycystic ovary syndrome: insulin enhances 5alpha-reduction but not the elevated adrenal steroid production rates.
Tsilchorozidou T; Honour JW; Conway GS
J Clin Endocrinol Metab; 2003 Dec; 88(12):5907-13. PubMed ID: 14671189
[TBL] [Abstract][Full Text] [Related]
10. Assessing systemic 11beta-hydroxysteroid dehydrogenase with serum cortisone/cortisol ratios in healthy subjects and patients with diabetes mellitus and chronic renal failure.
Homma M; Tanaka A; Hino K; Takamura H; Hirano T; Oka K; Kanazawa M; Miwa T; Notoya Y; Niitsuma T; Hayashi T
Metabolism; 2001 Jul; 50(7):801-4. PubMed ID: 11436185
[TBL] [Abstract][Full Text] [Related]
11. Cortisol metabolism in human obesity: impaired cortisone-->cortisol conversion in subjects with central adiposity.
Stewart PM; Boulton A; Kumar S; Clark PM; Shackleton CH
J Clin Endocrinol Metab; 1999 Mar; 84(3):1022-7. PubMed ID: 10084590
[TBL] [Abstract][Full Text] [Related]
12. Body fat distribution and cortisol metabolism in healthy men: enhanced 5beta-reductase and lower cortisol/cortisone metabolite ratios in men with fatty liver.
Westerbacka J; Yki-Järvinen H; Vehkavaara S; Häkkinen AM; Andrew R; Wake DJ; Seckl JR; Walker BR
J Clin Endocrinol Metab; 2003 Oct; 88(10):4924-31. PubMed ID: 14557475
[TBL] [Abstract][Full Text] [Related]
13. The syndrome of apparent mineralocorticoid excess: its association with 11 beta-dehydrogenase and 5 beta-reductase deficiency and some consequences for corticosteroid metabolism.
Monder C; Shackleton CH; Bradlow HL; New MI; Stoner E; Iohan F; Lakshmi V
J Clin Endocrinol Metab; 1986 Sep; 63(3):550-7. PubMed ID: 3460996
[TBL] [Abstract][Full Text] [Related]
14. Growth hormone replacement inhibits renal and hepatic 11 beta-hydroxysteroid dehydrogenases in ACTH-deficient patients.
Walker BR; Andrew R; MacLeod KM; Padfield PL
Clin Endocrinol (Oxf); 1998 Aug; 49(2):257-63. PubMed ID: 9828916
[TBL] [Abstract][Full Text] [Related]
15. Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle.
Stewart PM; Corrie JE; Shackleton CH; Edwards CR
J Clin Invest; 1988 Jul; 82(1):340-9. PubMed ID: 3164727
[TBL] [Abstract][Full Text] [Related]
16. Apparent cortisone reductase deficiency: a unique form of hypercortisolism.
Phillipov G; Palermo M; Shackleton CH
J Clin Endocrinol Metab; 1996 Nov; 81(11):3855-60. PubMed ID: 8923828
[TBL] [Abstract][Full Text] [Related]
17. Tissue-specific changes in peripheral cortisol metabolism in obese women: increased adipose 11beta-hydroxysteroid dehydrogenase type 1 activity.
Rask E; Walker BR; Söderberg S; Livingstone DE; Eliasson M; Johnson O; Andrew R; Olsson T
J Clin Endocrinol Metab; 2002 Jul; 87(7):3330-6. PubMed ID: 12107245
[TBL] [Abstract][Full Text] [Related]
18. [11 beta-hydroxysteroid-dehydrogenase: characteristics and the clinical significance of a key enzyme in cortisol metabolism].
Kerstens MN; Dullaart RP
Ned Tijdschr Geneeskd; 1999 Mar; 143(10):509-14. PubMed ID: 10321259
[TBL] [Abstract][Full Text] [Related]
19. Reduced 11beta-hydroxysteroid dehydrogenase activity in patients with the nephrotic syndrome.
Vogt B; Dick B; N'Gankam V; Frey FJ; Frey BM
J Clin Endocrinol Metab; 1999 Feb; 84(2):811-4. PubMed ID: 10022459
[TBL] [Abstract][Full Text] [Related]
20. Increased cortisol metabolites and reduced activity of 11beta-hydroxysteroid dehydrogenase in patients on hemodialysis.
N'Gankam V; Uehlinger D; Dick B; Frey BM; Frey FJ
Kidney Int; 2002 May; 61(5):1859-66. PubMed ID: 11967038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]